The executive team at Phoenicis has a history of working in the board of directors at Orphan Technologies, being the president/CEO at Valerion Therapeutics, and co-founding Alopexx Enterprises. They also have experience in vice president, regulatory affairs and clinical operations at Alexion Pharmaceuticals. The team is educated in biology and education from Boston College.
View all